World AffairsThe Indian Express•1 min read•10/12/2026 (2h ago)

India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs

India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs
60-Word AI Digest

India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs The Indian Express After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu Centre caps trade margin for cancer...

Key Takeaways

  • India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs
  • India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs The Indian Express After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu Centre caps trade margin for cancer drugs at 30% after Supreme Court rap Bar and Bench '400 times the cost': SC slams govt over drug pricing, asks to cap all medicines Rediff
  • Click full coverage link below for the complete official dispatch.

India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs The Indian Express After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu Centre caps trade margin for cancer drugs at 30% after Supreme Court rap Bar and Bench '400 times the cost': SC slams govt over drug pricing, asks to cap all medicines Rediff

Original Publisher Attribution

This summary was curated from The Indian Express.

Read Original on The Indian Express
India news Live Updates, 12 October 2026: Supreme Court questions Centre on capping margins beyond anti-cancer drugs — Loop60